farnesol has been researched along with dinoprostone in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aizman, E; Kloog, Y; Mor, A | 1 |
| Geginat, G; Krause, J; Tammer, I | 1 |
| Cheng, BH; Hu, TY; Lian, CL; Liu, JQ; Liu, ZQ; Qiu, SQ; Wang, CF; Xiao, L; Xu, Y | 1 |
3 other study(ies) available for farnesol and dinoprostone
| Article | Year |
|---|---|
Celecoxib enhances the anti-inflammatory effects of farnesylthiosalicylic acid on T cells independent of prostaglandin E(2) production.
Topics: Animals; Celecoxib; Cell Adhesion; Cell Line; Cyclooxygenase 2 Inhibitors; Dinoprostone; Drug Synergism; Extracellular Signal-Regulated MAP Kinases; Farnesol; Humans; Interleukin-2; Jurkat Cells; Mice; Mice, Inbred BALB C; Oncogene Protein p21(ras); Phosphorylation; Pyrazoles; Salicylates; Sulfonamides; T-Lymphocytes | 2012 |
Prostaglandin E2 from Candida albicans Stimulates the Growth of Staphylococcus aureus in Mixed Biofilms.
Topics: Biofilms; Candida albicans; Dinoprostone; Farnesol; Indomethacin; Staphylococcus aureus; Symbiosis | 2015 |
Two new farnesyl phenolic compounds with anti-inflammatory activities from Ganoderma duripora.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase 2; Dinoprostone; Drug Evaluation, Preclinical; Farnesol; Ganoderma; Interleukin-1beta; Interleukin-6; Lipopolysaccharides; Mice; Molecular Structure; NF-kappa B; Nitric Oxide; Phenols; RAW 264.7 Cells; Signal Transduction; Tumor Necrosis Factor-alpha | 2018 |